Efficacy and Safety of Chinese Herbal Formula Granules in Treating Chronic Kidney Disease Stage 3: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Table 16

Analysis of adverse events.

Variable	Treatment group (n, %)	Control group (n, %)	Statistics	value
Adverse event			1.86 (CHISQ test)	0.1721
Total (missing)	171 (0)	172 (0)
No	147 (85.96)	156 (90.70)
Yes	24 (14.04)	16 (9.30)